Drugs in Context

We are currently organizing a #TalentContest,  NEW TREATMENT OPTIONS FOR ADVANCED #ENDOMETRIALCARCINOMA   We are convinced that your work could make an excellent contribution and that your personal involvement would greatly increase its impact: we would be thrilled if you submitted a clinical case or research article. The (best) selected manuscripts will be published free of charge, open access, in #DRUGSinCONTEXT journal if you and your colleagues are interested in submitting a manuscript, contact us or submit your article at clinicalcontest@contentednet.com we are looking forward to hearing from you!

New article in Drugs in Context Pharmacovigilance monitoring and treatment adherence in patients on antihypertensive drugs at a tertiary care centre Pooja Agrawal, Shilpa Patrick, Meenu Thomas, Dhyuti Gupta, Dr Prithpal Singh Matreja, Preeti Singh, Shaneela Zafar Study evaluating hypertension medication adherence through the Morisky Medication Adherence Scale. #drugsincontext #pharmacovigilance #pharmacology #hypertension #medicationadherence #healthoutcomes https://lnkd.in/dkuTkc-4

New article in Drugs in Context Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences Silvia Alberti Violetti, Marco Ardigo, Paolo Fava, Giuseppe Gritti, Erika Morsia, Francesco Onida, Marco Paulli, Alessandro Pileri, Pietro Quaglino, Serena Rupoli, Miriam Teoli, Pamela Vezzoli Overview of clinical practice evidence on the diagnosis of mycosis fungoides and a collection of clinical experiences to better characterize the use of chlormethine gel in daily practice. #drugsincontext #dermatology #treatment #clinicalevidence #personalizedmedicine https://lnkd.in/ddtd-biy

New article in Drugs in Context Fixed-dose combination of calcipotriene/betamethasone dipropionate foam for the management of mild-to-moderate psoriasis in daily clinical practice: a collection of clinical experiences Anna Campanati, Maria Esposito, Giacomo Caldarola, sara cacciapuoti, Gabriella Fabbrocini Expert discussion of the value of fixed-dose combination of calcipotriene 0.005%/betamethasone dipropionate 0.064% (Cal/BD) aerosol foam as a topical treatment for mild-to-moderate psoriasis in combination with systemic treatments. #drugsincontext #dermatology #psoriasis #clinicalexperience #treatment https://lnkd.in/dtsAF_d4

We are excited to announce that Drugs in Context is now included in Clarivate's Master Journal List as part of the Emerging Sources Citation Index (ESCI) Core Collection. Publishing with us will now mean greater visibility, increased academic impact and improved publication metrics. Visit our website (https://lnkd.in/eqwdE9u) or contact our Managing Editor Rosanna L Gonzalez McQuire to find out more about the journal.

New article in Drugs in Context Clinical remission and control in severe asthma: agreements and disagreements Annamaria Bosi, Carlo Lombardi, Cristiano Caruso, Cottini Marcello, Ilaria Baglivo, Stefania Colantuono, Francesco Menzella Review discussing the evolution of the debated concept of clinical remission in asthma providing clinicians with insights that may be helpful in achieving remission in the greatest number of patients. #drugsincontext #asthma #severeasthma #respiratorydisease #immunology #allergiology #allergies #clinicalremission #inflammation #oralcorticosteroids https://lnkd.in/dGt4NZXx

New article in Drugs in Context Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVE Nicoletta Bernardini, Nevena Skroza, Laura Atzori, Cristina Mugheddu, Matteo Megna, Sara Cacciapuoti, Michela Ortoncelli, Maria Antonietta Montesu, Antonio Carpentieri, Martino Carriero, Maria G Atzori, Gianmario Addis, Riccardo Balestri, Giulia Rech, Pierluigi Bruni, Manuela Papini, Concetta Potenza Multicentre study focusing on psoriasis affecting sensitive areas (particularly the pretibial area), its impact on quality of life and the therapeutic response to risankizumab. https://lnkd.in/dD4gyrgF #drugsincontext #dermatology #psoriasis #mabs #qualityoflife #skin

New article in Drugs in Context RNA interference therapy in cardiology: will new targets improve therapeutic goals? Renata TJ Fazoli, Luciano Drager, Roberto Kalil-Filho, Giuliano Generoso Review highlighting the historical timeline of the development of siRNA-based drugs as well as their clinical indications in cardiology, potential side-effects and future perspectives. #drugsincontext #cardiology #pharmacology #RNAdrugs https://lnkd.in/eH3Yut7v

New article in Drugs in Context Risk of gastrointestinal bleeding in Asian patients receiving oral anticoagulants for stroke prevention in atrial fibrillation Alejandro Bimbo Diaz, Jeremy Chow, Fan Kee Hoo, Gary Lee Chin Keong, Narayanaswamy Venketasubramanian, Nannette Rey, Gregorio Rogelio, Radhika Mehta Report of the Asia Pacific Advancing Patient care with EdoXaban 2023 meeting, where experts shared insights on gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation in Asian clinical practice. #drugsincontext #stroke #anticoagulants #cardiology #atrialfibrillation https://lnkd.in/dkEXPJMk

New in Drugs in Context A UK multicentre audit of the management of patients with primary hypercholesterolaemia or mixed dyslipidaemia with bempedoic acid against published lipid-lowering treatment targets Sudarshan Ramachandran, Amro Maarouf, Karen Mitchell, Tony Avades, Peter Smith, Lee Boulton, Jennifer Kelly, Nitasha Vekaria, Elizabeth Hughes Audit highlighting the role of bempedoic acid as part of combination therapy for a population with previously limited treatment options. #drugsincontext #cardiology #dyslipidaemia #hypercholesterolaemia https://lnkd.in/eStqmzxF